Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic PainDavid M. Simpson, Geertrui F. Vanhove, Suzanne Gazda et al.|Journal of Pain and Symptom Management|2010Cited by 107
A Multicenter, Randomized, Double-Blind, Controlled Dose Finding Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic NeuralgiaLynn R. Webster, Geertrui F. Vanhove, T. Philip Malan et al.|Journal of Pain|2010Cited by 88
NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic NeuralgiaGordon Irving, Geertrui F. Vanhove, Miroslav Bačkonja et al.|Clinical Journal of Pain|2011Cited by 68
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT RecommendationsJennifer S. Gewandter, James Witter, Robert H. Dworkin et al.|Journal of Pain|2019Cited by 58
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgiaLynn R. Webster, Geertrui F. Vanhove, Marvin Tark et al.|BMC Neurology|2010Cited by 55